3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
69
Gynecologic
21
Gastrointestinal
10
Genitourinary
9
Classical hematology
5
Thoracic
3
Sarcoma
2
Lymphoid
2
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Head & Neck
1
CNS
1
Conditions
Glioma
8
Glioblastoma
7
Recurrence
3
Osteosarcoma
3
Neuroblastoma
3
Medulloblastoma
3
Ependymoma
3
Central Nervous System Neoplasms
3
Wilms Tumor
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Pheochromocytoma
2
Paraganglioma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Lymphoma, Non-Hodgkin
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Cholangiocarcinoma
2
Brain Neoplasms
2
Xanthogranuloma, Juvenile
1
Sarcoma, Synovial
1
Sarcoma, Ewing
1
Neuroendocrine Tumors
1
Meningioma
1
Histiocytic Sarcoma
1
Gliosarcoma
1
Familial ependymoma
1
Esthesioneuroblastoma, Olfactory
1
Breast Neoplasms
1
Interventions
Trastuzumab
20
Radiosurgery
15
Magnetic Resonance Spectroscopy
15
Capecitabine
14
Lapatinib
12
Radiotherapy
11
Specimen Handling
10
Cyclophosphamide
9
trastuzumab deruxtecan
8
Temozolomide
8
Docetaxel
8
Paclitaxel
7
Gemcitabine
6
Cisplatin
6
sacituzumab govitecan
5
Vinorelbine
5
Therapeutics
5
Spinal Puncture
5
Flow Cytometry
5
tucatinib
4
pembrolizumab
4
paclitaxel-Angiopep-2 conjugate
4
eribulin
4
Methotrexate
4
Irinotecan
4
Fluorodeoxyglucose F18
4
Dexamethasone
4
Bevacizumab
4
temsirolimus
3
pyrotinib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
olaparib
×
CNS
×
Clear all
NCT04711824
2025-12-23
SOLARA
Hoosier Cancer Research Network
Phase 1/2
Recruiting
41 enrolled